🇺🇸 FDA
Patent

US 7157476

Aminofurazan compounds useful as protein kinase inhibitors

granted A61PA61P1/04A61P1/16

Quick answer

US patent 7157476 (Aminofurazan compounds useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P1/04, A61P1/16, A61P11/06, A61P13/08